Rescheduling Questions: How the Marijuana Landscape Could Soon Change
A White House Executive Order to expedite the rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.
This edition of RxInformer continues to monitor evolving trends in workers’ comp, from escalating costs in durable medical equipment (DME), using digital strategies to drive positive patient engagement, an increase in occupational lung disease, and more.
A White House Executive Order to expedite the rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.
A review of strategies to help ignite desirable behaviors in injured workers and encourage active participation in recovery, including practical tips and metrics for achieving tangible results.
Unfamiliarity with workers’ comp is one of the biggest barriers to recovery for injured worker patients. How can we use meaningful engagement to help them navigate the system?
Demand for DME is rising, as are costs. What’s driving this growth, and how can the workers’ compensation industry contain costs?
These diseases are infrequent in workers' comp, but they can incur significant costs as these diseases are often present for life, requiring ongoing monitoring, treatment, and medication.
Healthesystems’ Sandy Shtab examines key workers’ comp policy trends, from PBM regulation and AI oversight to marijuana rescheduling and injured worker engagement.
